Titre:
  • Reduced cholecystokinin levels in cerebrospinal fluid of parkinsonian and schizophrenic patients. Effect of ceruletide in schizophrenia
Auteur:Lotstra, Françoise; Verbanck, Paul; Gilles, Christian; Mendlewicz, Julien; Vanderhaeghen, Jean-Jacques
Informations sur la publication:Annals of the New York Academy of Sciences, 448, page (507-517)
Statut de publication:Publié, 1985-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Caerulein -- therapeutic use
Cholecystokinin -- cerebrospinal fluid
Clinical Trials as Topic
Dopamine -- secretion
Double-Blind Method
Female
Humans
Male
Middle Aged
Parkinson Disease -- cerebrospinal fluid
Schizophrenia -- cerebrospinal fluid
Schizophrenia -- drug therapy
Note publication spéciale:Neuronal Cholecystokinin
Note générale:Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: NotDefined.j
FLWNA
Langue:Anglais
Identificateurs:urn:issn:0077-8923
info:doi/10.1111/j.1749-6632.1985.tb29944.x
info:scp/0022271315
info:pmid/3896098
VX-025578